AthenaHealth hosed by IPO process?
updated
AthenaHealth, a company that sells software to doctors to manage their billing and other office tasks, is just the latest company to appear cheated by the IPO process: It’s bankers helped it price the stock at $18, but by the end of the first day of trading, it was at $35.50.
That suggests the Watertown, Mass company could have sold its shares for much more, say $25 or $30, and still had decent demand from investors.
Here’s… Continue Reading
Life sciences briefing: Thursday, Sept. 20, 2007
Featured companies: Allergan, Athenahealth, Atria Genetics, Celera, Esprit Pharmaceuticals, Vida Diagnostics
(NOTE: This item was posted on Friday, 9/21/07. I’ve backdated its timestamp to preserve the chronological order of the briefings.)
Celera buys Atria Genetics for $33M — Rockville, Md.-based Celera, the onetime genomics pioneer still working to turn itself into a diagnostics company, agreed to pay $33 million to acquire Atria Genetics of South San Francisco, Calif. (Atria doesn’t seem to have a Web site, and if… Continue Reading
Athenahealth files for $86M IPO
Athenahealth, a Watertown, Mass., maker of health IT systems for billing and management of electronic health records, filed to raise as much as $86.25 million in an initial offering. The company’s SEC filing is here.
Athenahealth’s systems work as Web-based services, a strategy designed to take advantage of the Internet’s flexibility and to make it easier for doctors to digitize their practices without making a huge amount of up-front investment. That said, Athenahealth’s business is still… Continue Reading